Augmenting neurocognitive remediation therapy to Preventive Cognitive Therapy for partially remitted depressed patients: protocol of a pragmatic multicentre randomised controlled trial
Introduction Major depressive disorder (MDD) affects 163 million people globally every year. Individuals who experience subsyndromal depressive symptoms during remission (ie, partial remission of MDD) are especially at risk for a return to a depressive episode within an average of 4 months. Simultan...
Saved in:
| Main Authors: | Huibert Burger, Claudi Bockting, Marlies Brouwer, Gert J Geurtsen, Amanda M Legemaat, Johanne G J van der Stappen, Maria Semkovska, Isidoor O Bergfeld, Nicoline Lous, Damiaan A J P Denys |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-06-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/6/e063407.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Personalised app-based relapse prevention of depressive and anxiety disorders in remitted adolescents and young adults: a protocol of the StayFine RCT
by: Claudi Bockting, et al.
Published: (2022-12-01) -
Effectiveness of Attachment-Based Family Therapy for Suicidal Adolescents and Young Adults: A Systematic Review and Meta-Analysis
by: Poul M. Schulte-Frankenfeld, et al.
Published: (2024-12-01) -
Double trouble: does co-morbid chronic somatic illness increase risk for recurrence in depression? A systematic review.
by: Gemma D Kok, et al.
Published: (2013-01-01) -
Modern dilemma in the therapy of the schizophrenia: neurocognition and social cognition
by: N. B. Lutova, et al.
Published: (2019-10-01) -
Neurocognitive function in HIV infected patients on antiretroviral therapy.
by: Alan Winston, et al.
Published: (2013-01-01)